PHARM MANUF/DISTR DIV - FSA

The Defense Logistics Agency is preparing to solicit a national requirements contract for Febuxostat Tablets in 40 MG and 80 MG strengths, packaged in 30-count bottles, under solicitation number SPE2D2-26-R-0012. This is an unrestricted, fully competitive acquisition classified as a commercial item under FAR Part 12, with a firm-fixed price structure and a one-year base period plus four one-year options. The contract will serve as the sole national supply source for the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service, supplying these entities through DLA and VA prime vendor programs. Annual usage estimates will be detailed in the solicitation’s Schedule of Supplies, and the contract will be governed by FAR 52.216-21 (Requirements). The NAICS code for this procurement is 325412, and it is managed by DLA Troop Support out of Philadelphia, Pennsylvania. The solicitation is set to be posted on DIBBS and SAM.gov, with a projected release date in June 2026, though DLA retains the right to issue it earlier or later. Interested vendors are encouraged to monitor these platforms and set up automated notifications for any updates. Questions or comments may be directed to Christopher Newman at Christopher.Newman@dla.mil or (445) 737-7371, with Jason C. Wray listed as a secondary point of contact. All responsible sources may submit proposals, and the contract will be awarded based on competitive evaluation without set-asides, ensuring broad market access.